Cancer Epidemiology Biomarkers & Prevention, Vol 6, Issue 6 469-471, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis

G Biasco, U Zannoni, GM Paganelli, R Santucci, P Gionchetti, G Rivolta, R Miniero, L Pironi, C Calabrese, G Di Febo and M Miglioli
Centro Interdipartimentale di Ricerche sul Cancro G. Prodi e Istituto di Ematologia e Oncologia Medica L. e A. Seragnoli, Milano, Italy.

It has been suggested that colon cancer risk in ulcerative colitis (UC) is correlated to a reduced bioavailability of folate. We studied the effects of folate supplementation on the pattern of rectal cell proliferation in patients affected by long-standing UC. In the rectal mucosa of these patients, an expansion of proliferating cells to the crypt surface is found frequently. This abnormality is considered an intermediate biomarker in chemoprevention trials. Twenty-four patients (13 males; age, 26-70 years; UC duration, 7-34 years) with UC in remission for 1 month at least were assigned randomly to one of the following treatments: (a) folinic acid (15 mg/day) or (b) placebo. Cell proliferation was analyzed through immunohistochemistry on sections of rectal biopsies incubated for 1 hour in a culture medium containing bromodeoxyuridine. Fragments were taken at admission to the study and after 3 months of treatment. As compared to the baseline values, after 3 months of therapy in patients treated with folinic acid, a significant reduction of the frequency of occurrence of labeled cells in the upper 40% of the crypts (phi h value) was observed (0.1836 +/- 0.0278 versus 0.1023 +/- 0.0255; P < 0.01). On the contrary, no significant proliferative changes were observed in the placebo group. These results suggest that folate supplementation contributes to regulating rectal cell proliferation in patients with long-standing UC. These findings may be significant for chemoprevention of colon cancer in these patients.

This article has been cited by other articles:

				A. Pompei, L. Cordisco, A. Amaretti, S. Zanoni, S. Raimondi, D. Matteuzzi, and M. Rossi Administration of Folate-Producing Bifidobacteria Enhances Folate Status in Wistar Rats J. Nutr., December 1, 2007; 137(12): 2742 - 2746. [Abstract] [Full Text] [PDF]

				H. J. Powers, M. H. Hill, M. Welfare, A. Spiers, W. Bal, J. Russell, Y. Duckworth, E. Gibney, E. A. Williams, and J. C. Mathers Responses of Biomarkers of Folate and Riboflavin Status to Folate and Riboflavin Supplementation in Healthy and Colorectal Polyp Patients (The FAB2 Study) Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2128 - 2135. [Abstract] [Full Text] [PDF]

				A. Pompei, L. Cordisco, A. Amaretti, S. Zanoni, D. Matteuzzi, and M. Rossi Folate Production by Bifidobacteria as a Potential Probiotic Property Appl. Envir. Microbiol., January 1, 2007; 73(1): 179 - 185. [Abstract] [Full Text] [PDF]

				G. R. Wasson, A. P. McGlynn, H. McNulty, S. L. O'Reilly, V. J. McKelvey-Martin, G. McKerr, J. J. Strain, J. Scott, and C. S. Downes Global DNA and p53 Region-Specific Hypomethylation in Human Colonic Cells Is Induced by Folate Depletion and Reversed by Folate Supplementation J. Nutr., November 1, 2006; 136(11): 2748 - 2753. [Abstract] [Full Text] [PDF]

				H. J. Powers Interaction among Folate, Riboflavin, Genotype, and Cancer, with Reference to Colorectal and Cervical Cancer J. Nutr., December 1, 2005; 135(12): 2960S - 2966S. [Abstract] [Full Text] [PDF]

				D. W.L. Ma, R. H. Finnell, L. A. Davidson, E. S. Callaway, O. Spiegelstein, J. A. Piedrahita, J. M. Salbaum, C. Kappen, B. R. Weeks, J. James, et al. Folate Transport Gene Inactivation in Mice Increases Sensitivity to Colon Carcinogenesis Cancer Res., February 1, 2005; 65(3): 887 - 897. [Abstract] [Full Text] [PDF]

				Y.-I. Kim Folate and DNA Methylation: A Mechanistic Link between Folate Deficiency and Colorectal Cancer? Cancer Epidemiol. Biomarkers Prev., April 1, 2004; 13(4): 511 - 519. [Abstract] [Full Text] [PDF]

				J. Carrier, A. Medline, K.-J. Sohn, M. Choi, R. Martin, S. W. Hwang, and Y.-I. Kim Effects of Dietary Folate on Ulcerative Colitis-Associated Colorectal Carcinogenesis in the Interleukin 2- and {beta}2-Microglobulin-deficient Mice Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1262 - 1267. [Abstract] [Full Text]

				Y.-I. Kim Role of Folate in Colon Cancer Development and Progression J. Nutr., November 1, 2003; 133(11): 3731S - 3739. [Abstract] [Full Text] [PDF]

				S.-W. Choi, S. Friso, G. G. Dolnikowski, P. J. Bagley, A. N. Edmondson, D. E. Smith, and J. B. Mason Biochemical and Molecular Aberrations in the Rat Colon Due to Folate Depletion Are Age-Specific J. Nutr., April 1, 2003; 133(4): 1206 - 1212. [Abstract] [Full Text] [PDF]

				K Khosraviani, H P Weir, P Hamilton, J Moorehead, and K Williamson Effect of folate supplementation on mucosal cell proliferation in high risk patients for colon cancer Gut, August 1, 2002; 51(2): 195 - 199. [Abstract] [Full Text] [PDF]

				S.-W. Choi and J. B. Mason Folate Status: Effects on Pathways of Colorectal Carcinogenesis J. Nutr., August 1, 2002; 132(8): 2413S - 2418. [Abstract] [Full Text] [PDF]

				J.-P. J. Issa, N. Ahuja, M. Toyota, M. P. Bronner, and T. A. Brentnall Accelerated Age-related CpG Island Methylation in Ulcerative Colitis Cancer Res., May 1, 2001; 61(9): 3573 - 3577. [Abstract] [Full Text]

				E. T. Hawk and J. L. Viner Chemoprevention in Ulcerative Colitis: Narrowing the Gap between Clinical Practice and Research Ann Intern Med, January 16, 2001; 134(2): 158 - 160. [Full Text] [PDF]